Search | OpenScholar

Search results

2011 results found

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results

Publication: Journal Article

Investigators, The NINDS NET-PD, and RA Hauser. 2008. “A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results”. Clin Neuropharmacol.

A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.

Publication: Journal Article

Olanow, CW, RA Hauser, J Jankovic, W Langston, A Lang, W Poewe, E Tolosa, et al. 2008. “A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline As a Disease Modifying Therapy in Parkinson’s Disease (the ADAGIO Study): Rationale, Design, and Baseline Characteristics.”. Mov Disord.

Tiagabine and exacerbation of essential tremor.

Publication: Journal Article

Zesiewicz, TA, CL Ward, and RA Hauser. 2007. “Tiagabine and Exacerbation of Essential Tremor.”. Mov Disord.

Role of the pharmacist in the effective management of wearing-off in Parkinson’s disease.

Publication: Journal Article

Simonson, W, RA Hauser, and AH Shapira. 2007. “Role of the Pharmacist in the Effective Management of Wearing-off in Parkinson’s Disease.”. Ann Pharmacother.

Ten-year follow-up of Parkinson’s disease patients randomized to initial therapy with ropinirole or levodopa.

Publication: Journal Article

Hauser, RA, O Rascol, AD Korczyn, Jon Stoessl, RL Watts, W Poewe, PP De Deyn, and AE Lang. 2007. “Ten-Year Follow-up of Parkinson’s Disease Patients Randomized to Initial Therapy With Ropinirole or Levodopa.”. Mov Disord.

Tegaserod (Zelnorm) for the treatment of constipation in Parkinson’s disease.

Publication: Journal Article

Sullivan, KL, JK Staffetti, RA Hauser, PB Dunne, and TA Zesiewicz. 2006. “Tegaserod (Zelnorm) for the Treatment of Constipation in Parkinson’s Disease.”. Movement Disorders.

Clinical trials aimed at detecting neuroprotection in Parkinson’s disease.

Publication: Journal Article

Hauser, RA, and T Zesiewicz. 2006. “Clinical Trials Aimed at Detecting Neuroprotection in Parkinson’s Disease.”. Neurology.

Use of nutritional supplements in Parkinson’s disease patients.

Publication: Journal Article

Wolfrath, SC, AR Borenstein, S Schwartz, RA Hauser, KL Sullivan, and TA Zesiewicz. 2006. “Use of Nutritional Supplements in Parkinson’s Disease Patients.”. Movement Disorders.

Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Arch Neurol 2006;63:1181-1184.

Publication: Journal Article

Graff-Radford, J, KD Foote, RL Rodriguez, HH Fernandez, RA Hauser, and . 2006. “Deep Brain Stimulation of the Internal Segment of the Globus Pallidus in Delayed Runaway Dyskinesia. Arch Neurol 2006;63:1181-1184.”. Arch Neurol.

Levodopa/carbidopa/entacapone for the treatment of Parkinson’s disease.

Publication: Journal Article

Samanta, J, and RA Hauser. 2006. “Levodopa/Carbidopa/Entacapone for the Treatment of Parkinson’s Disease.”. Aging Health.